Dong Young Kang
Overview
Explore the profile of Dong Young Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sp N, Kang D, Lee J, Bae S, Jang K
Int J Mol Sci
. 2021 Apr;
22(9).
PMID: 33925065
Hormone-specific anticancer drugs for breast cancer treatment can cause serious side effects. Thus, treatment with natural compounds has been considered a better approach as this minimizes side effects and has...
12.
Kang D, Sp N, Jo E, Rugamba A, Kim H, Kim I, et al.
Mol Med Rep
. 2021 Apr;
24(1).
PMID: 33907855
Janus kinase 2 (JAK2) and STAT3 signaling is considered a major pathway in lipopolysaccharide (LPS)‑induced inflammation. Toll‑like receptor 4 (TLR‑4) is an inflammatory response receptor that activates JAK2 during inflammation....
13.
Kang D, Sp N, Lee J, Jang K
Biomedicines
. 2021 Apr;
9(3).
PMID: 33805840
Targeted therapy based on natural compounds is one of the best approaches against non-small cell lung cancer. Ursolic acid (UA), a pentacyclic triterpenoid derived from medicinal herbs, has anticancer activity....
14.
Kim D, Kang D, Sp N, Jo E, Rugamba A, Jang K, et al.
Anticancer Res
. 2020 Sep;
40(9):5191-5200.
PMID: 32878807
Background/aim: Colorectal cancer is one of the most common malignancies worldwide. Small molecule-based chemotherapy is an attractive approach for the chemoprevention and treatment of colorectal cancer. Methylsulfonylmethane (MSM) is a...
15.
Sp N, Kang D, Kim D, Yoo J, Jo E, Rugamba A, et al.
Anticancer Res
. 2020 Jun;
40(6):3209-3220.
PMID: 32487615
Background/aim: Non-small cell lung cancer (NSCLC) is one among the most common cancers worldwide. Recently, dietary phytochemicals have been reported as an attractive approach to improve the symptoms of NSCLC...
16.
Jo E, Sp N, Kang D, Rugamba A, Kim I, Bae S, et al.
Molecules
. 2020 May;
25(10).
PMID: 32429534
High glucose-induced inflammation leads to atherosclerosis, which is considered a major cause of death in type 1 and type 2 diabetic patients. Nuclear factor-kappa B (NF-κB) plays a central role...
17.
Kim D, Sp N, Kang D, Jo E, Rugamba A, Jang K, et al.
Anticancer Res
. 2020 Apr;
40(4):1905-1913.
PMID: 32234879
Background/aim: Methylsulfonylmethane (MSM) is a natural organic compound that displays anti-inflammatory as well as antioxidant properties. MSM reportedly has potential in inhibition of tumor cells. However, molecular mechanisms underlying the...
18.
Kang D, Sp N, Jo E, Rugamba A, Hong D, Lee H, et al.
Cancers (Basel)
. 2020 Mar;
12(3).
PMID: 32204508
Non-small-cell lung cancer (NSCLC) is the most common lung cancer subtype and accounts for more than 80% of all lung cancer cases. Epidermal growth factor receptor (EGFR) phosphorylation by binding...
19.
Jang K, Jeong S, Kang D, Sp N, Yang Y, Kim D
Sci Rep
. 2020 Mar;
10(1):4481.
PMID: 32161317
Severe acute respiratory syndrome coronavirus nonstructural protein 13 (SCV nsP13), a superfamily 1 helicase, plays a central role in viral RNA replication through the unwinding of duplex RNA and DNA...
20.
Sp N, Kang D, Jo E, Rugamba A, Kim W, Park Y, et al.
Cells
. 2020 Jan;
9(2).
PMID: 31979292
Human embryonic carcinoma (EC; NCCIT) cells have self-renewal ability and pluripotency. Cancer stem cell markers are highly expressed in NCCIT cells, imparting them with the pluripotent nature to differentiate into...